Patent ID: 7507531
Filing Date: 2009-03-24
Classification: A01K,C07K,C12Q,G01N

Abstract:
1. A method of assessing susceptibility to myocardial infarction (MI) in a human individual, the method comprising: screening nucleic acid of the individual to determine whether the nucleic acid comprises a 5-lipoxygenase activating protein (FLAP) haplotype that comprises polymorphisms SG13S114, allele T; SG13S32, allele A; SG13S25, allele G; and SG13S89, allele G; wherein the presence of the haplotype in the nucleic acid of the individual identifies the individual as having elevated susceptibility to MI, and wherein the absence of the haplotype in the nucleic acid of the individual identifies the individual as not having the elevated susceptibility to MI due to the haplotype.